Understanding Gadolinium-Based Contrast Agents: A Primer for Health-System Pharmacists

Health-System Edition, January 2015, Volume 4, Issue 1

This activity is supported by an educational grant from Guerbet LLC.

Understanding Gadolinium-Based Contrast Agents: A Primer for Health-System Pharmacists

Emanuel Kanal, MD, FACR, FISMRM, AANG

Director, Magnetic Resonance Services

Professor of Radiology and

Neuroradiology

Department of Radiology

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania

Educational Objectiaves

At the conclusion of this educational activity, participants should be able to:

  • Explain the clinical benefit of neuroradiologic gadolinium-based contrast agents (GBCAs), and the differences among available products
  • Recall the relationship between GBCAs and nephrogenic systemic fibrosis (NSF)
  • Recognize differences among the FDA-approved neuroradiologic GBCAs and their NSF—related risks
  • Recognize late-breaking concerns regarding the safety of GBCAs

Target audience:

Pharmacists

Type of activity:

Knowledge

Release date:

January 6, 2015

Expiration date:

January 6, 2017

Estimated time to complete activity:

2.0 hour

Fee:

This lesson is offered free at www.pharmacytimes.org

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-113-H04-P. The activity is available for CE credit through January 6, 2017.